Latest Safety News

Melbana Energy halts direct involvement in its Cuban Block 9 project following US sanctions on CUPET, its contractual counterparty, while it seeks legal clarity on the complex regulatory landscape.

Actinogen Medical’s pivotal XanaMIA Alzheimer’s trial has passed a third independent safety review, endorsing continuation without changes. Final topline efficacy data is expected in November 2026.

Meteoric Resources has secured key federal endorsements for its Caldeira Rare Earth Project’s environmental licensing, keeping the Installation License on schedule for December 2026 and paving the way for a final investment decision.

Cadoux Ltd has secured a key qualification for its premiumHPA® high-purity alumina, reinforcing its role in the EU-backed SAFELOOP lithium-ion battery development consortium focused on next-generation EV batteries.

HITIQ Limited secured a Federal Court order extending the quotation period for its HIQOA listed options on the ASX, resolving a regulatory timing issue and validating the delayed admission.

Island Pharmaceuticals has presented encouraging Phase 2a results for its dengue antiviral ISLA-101, demonstrating safety, effective blood concentrations, and meaningful viral load reductions at the Asia Dengue Summit.

Firebird Metals has placed all critical equipment orders for its Perth-based Australian Demonstration Plant, triggering the first ARENA grant payment and setting the stage for a pivotal 90-day fabrication phase. The project remains on track for early Q4 2026 equipment delivery, with imminent lithium manganese rich cathode results expected from its China pilot plant.

Critical Resources has achieved a key milestone by depositing a complete solid-state battery cathode layer in one dry, solvent-free step, potentially simplifying and cutting costs in battery production for high-demand sectors.

Bass Oil lifted May production by 5% with a 219 barrels per day average, while drilling commenced on the Bunian 6 well, expected to double group output.

Paradigm Biopharmaceuticals has completed enrolment ahead of schedule in its pivotal Phase 3 trial for Zilosul®, enrolling 538 patients with knee osteoarthritis and maintaining its timeline for interim and final results.

icetana AI has scored its first commercial wins for Antara Core, an on-premise AI surveillance platform, with prepaid contracts worth $617,000 from Millennium Services Group. The deal also debuts its floor hazard detection technology in major Australian shopping centres.

Evolution Energy Minerals (ASX:EV1) is set to launch its maiden drilling campaign at Tanzania's Chikundo Copper Project, targeting multiple high-confidence copper anomalies defined by recent soil sampling and historical data.